Drug Shortage Report for SANDOZ FINASTERIDE
Report ID | 123416 |
Drug Identification Number | 02322579 |
Brand name | SANDOZ FINASTERIDE |
Common or Proper name | SANDOZ FINASTERIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | FINASTERIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 FCT UD CA |
ATC code | G04CB |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-08-28 |
Estimated end date | 2021-03-05 |
Actual end date | 2021-03-05 |
Shortage status | Resolved |
Updated date | 2021-03-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-03-08 | French | Compare |
v7 | 2021-03-08 | English | Compare |
v6 | 2021-01-18 | French | Compare |
v5 | 2021-01-18 | English | Compare |
v4 | 2020-12-07 | French | Compare |
v3 | 2020-12-07 | English | Compare |
v2 | 2020-08-31 | French | Compare |
v1 | 2020-08-31 | English | Compare |
Showing 1 to 8 of 8